Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nadia El-Gabalawy"'
Autor:
Carmen Charlton, Jamil Kanji, Vanessa Tran, Julianne Kus, Jonathan Gubbay, Carla Osiowy, Jason Robinson, Inna Sekirov, Michael Drebot, Todd Hatchette, Derek Stein, Nadia El-Gabalawy, Amanda Lang, Lei Jiao, Paul Levett, Heidi Wood, Christian Therrien, L Robbin Lindsay, Muhammad Morshed, Jessica Forbes, Antonia Dibernardo
Publikováno v:
Canada Communicable Disease Report, Vol 47, Iss 4, Pp 171-183 (2021)
The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic testing is rapidly evolving. While serology testing has limited diagnostic capacity for acute infection, its role in providing population-based information on
Externí odkaz:
https://doaj.org/article/e43ae1b010cc405db886e97ce6d57a3e
Autor:
Carmen Charlton, Jamil Kanji, Vanessa Tran, Julianne Kus, Jonathan Gubbay, Carla Osiowy, Jason Robinson, Inna Sekirov, Michael Drebot, Todd Hatchette, Derek Stein, Nadia El-Gabalawy, Amanda Lang, Lei Jiao, Paul Levett, Heidi Wood, Christian Therrien, L Robbin Lindsay, Muhammad Morshed, Jessica Forbes, Antonia Dibernardo
Publikováno v:
Canada Communicable Disease Report, Vol 47, Iss 4, Pp 187-100 (2021)
Le répertoire des tests de diagnostic disponibles du coronavirus du syndrome respiratoire aigu sévère 2 (SRAS-CoV-2) évolue rapidement. Bien que les tests sérologiques aient une capacité de diagnostic limitée concernant l’infection aiguë, l
Externí odkaz:
https://doaj.org/article/09a47cbaa79548ea8a5a133da542b685
Autor:
Asher Begleiter, Nadia El-Gabalawy, Laurie Lange, Marsha K. Leith, Lynn J. Guziec, Frank S. Guziec Jr
Publikováno v:
Drug Target Insights, Vol 2009, Iss 4, Pp 1-8 (2009)
NQO1 (NAD(P)H:quinoneoxidoreductase 1) is a reductive enzyme that is an important activator of bioreductive antitumor agents. NQO1 activity varies in individual tumors but is generally higher in tumor cells than in normal cells. NQO1 has been used as
Externí odkaz:
https://doaj.org/article/69737853a199495b94c1ec8fd990296c
Autor:
Asher Begleiter, Nadia El-Gabalawy, Laurie Lange, Marsha K. Leith, Lynn J. Guziec, Frank S. Guziec Jr
Publikováno v:
Drug Target Insights, Vol 4, Iss 1 (2009)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/0f861a75747f4c1f97dc85726c56b6f0
Autor:
Asher Begleiter, Nadia El-Gabalawy, Laurie Lange, Marsha K. Leith, Lynn J. Guziec, Frank S. Guziec
Publikováno v:
Drug Target Insights, Vol 4 (2009)
NQO1 (NAD(P)H:quinoneoxidoreductase 1) is a reductive enzyme that is an important activator of bioreductive antitumor agents. NQO1 activity varies in individual tumors but is generally higher in tumor cells than in normal cells. NQO1 has been used as
Externí odkaz:
https://doaj.org/article/86a00a54cb304a71b831e26a879caa3f
Autor:
Julianne V. Kus, Carla Osiowy, Richard Garceau, Muhammad Morshed, Guillaume Desnoyers, Michael A. Drebot, Jonathan B. Gubbay, L. Robbin Lindsay, Michel Roger, Carmen L. Charlton, Bouchra Serhir, Denise Fudge, Ihssan Bouhtiauy, Vandana Mohan, Paul N. Levett, Vanessa Tran, Antonia Dibernardo, Nadia El-Gabalawy, Christian Therrien, George Zahariadis, Lei Jiao, Ainsley Gretchen, Robert Needle, Laura Gilbert, Derek R. Stein, Graham Tipples, Jamil N. Kanji, Inna Sekirov, Amanda Lang, Laurel Thorlacius, Jean Longtin
Publikováno v:
Diagnostic Microbiology and Infectious Disease
The COVID-19 pandemic has led to the influx of immunoassays for the detection of antibodies towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the global market. The Canadian Public Health Laboratory Network Serology Task Force
Autor:
Frank S. Guziec, Marsha K. Leith, Asher Begleiter, Laurie Lange, Nadia El-Gabalawy, Lynn J. Guziec
Publikováno v:
Drug Target Insights, Vol 4 (2009)
Drug Target Insights
Drug Target Insights
NQO1 (NAD(P)H:quinoneoxidoreductase 1) is a reductive enzyme that is an important activator of bioreductive antitumor agents. NQO1 activity varies in individual tumors but is generally higher in tumor cells than in normal cells. NQO1 has been used as